Guidelines: NCCN Guidelines (Poland): Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{forproviders}} | {{forproviders}} | ||
Go back to [[Poland]] page | Go back to [[Poland]] page | ||
'''Primary purpose:''' To assist clinicians in determining appropriate and effective avenues of care. | |||
'''Sponsor, manager or home institution:''' National Comprehensive Cancer Network (NCCN) and Norodowy Intytut Onkologii. | '''Sponsor, manager or home institution:''' National Comprehensive Cancer Network (NCCN) and Norodowy Intytut Onkologii. | ||
'''Type of information:''' Clinical recommendations, treatments, follow up, quality of life, of breast cancer, colon cancer, melanoma, non-small cell lung cancer, prostate cancer and squamous cell skin cancer. | '''Type of information:''' Clinical recommendations, treatments, follow up, quality of life, of breast cancer, colon cancer, melanoma, non-small cell lung cancer, prostate cancer and squamous cell skin cancer. | ||
Revision as of 21:51, 10 June 2024
Go back to Poland page
Primary purpose: To assist clinicians in determining appropriate and effective avenues of care.
Sponsor, manager or home institution: National Comprehensive Cancer Network (NCCN) and Norodowy Intytut Onkologii.
Type of information: Clinical recommendations, treatments, follow up, quality of life, of breast cancer, colon cancer, melanoma, non-small cell lung cancer, prostate cancer and squamous cell skin cancer.
Cancer areas of interest: C50: Breast cancer,C15-C26: Digestive system cancers, C43-C44: Skin cancers/melanoma, C30-C39: Lung/chest cancers, C60-C63: Male genitalia cancer. Click here to learn more
Access to information: List of guidelines Click here to access, in European editions: Poland (Is necessary to create a login to access the information).
